Is Declining Phosphatidylcholine a Driver of Mitochondrial Ageing?

A new study published in Nature Communications suggests that a decline in phosphatidylcholine (PC) synthesis may be an important and previously underappreciated driver of mitochondrial ageing. Using a combination of proteomics, lipidomics, genetics and functional testing in Caenorhabditis elegans (a tiny, transparent roundworm), the researchers showed that expression of key enzymes involved in PC synthesis progressively declines with age. This leads to fragmentation of mitochondrial networks, impaired mitochondrial respiration and loss of metabolic flexibility. Importantly, these age-related changes were partially reversed by supplementation with phosphatidylcholine or its precursor choline, restoring a more youthful mitochondrial structure and function. The study also incorporated human transcriptomic, metabolomic and cell-culture data to suggest that similar mechanisms may operate in people.

The work is scientifically robust because it establishes a mechanistic chain of evidence in an intact organism. The authors demonstrated that genetic suppression of PC synthesis in young worms reproduced features of mitochondrial ageing, while restoration of PC levels reversed many of these defects. This was supported by measurements of mitochondrial morphology, oxygen consumption and lipid composition.

However, the human data are largely associative, showing age-related reductions in expression of the human PC-synthesising enzyme PEMT and declines in PC-related metabolites, particularly around the menopausal transition, together with evidence that choline can improve resilience to mitochondrial stress in cultured human cells. The study therefore provides biological plausibility for human relevance but does not demonstrate clinical benefits in people.

The concept itself is not entirely new. Choline and phosphatidylcholine have long been recognised as essential components of cellular and mitochondrial membranes, and previous research has shown that choline deficiency can impair mitochondrial function, energy metabolism and fatty-acid oxidation.

The novelty of this paper lies in identifying declining PC synthesis as a potentially reversible driver of natural mitochondrial ageing rather than merely a consequence of age-related deterioration. In this respect, the work shifts attention from mitochondrial DNA damage and oxidative injury toward membrane lipid homeostasis as a fundamental determinant of mitochondrial health.

The translational implications are intriguing but remain speculative. The findings raise the possibility that nutritional strategies aimed at maintaining PC through choline, PC-rich foods, or targeted supplementation with lecithin or PC itself, could help preserve mitochondrial function and metabolic resilience with age.

Note that lecithin typically contains only 10% to 25% phosphatidylcholine, depending on the source (such as soy or sunflower), with the remainder being other fats and plant compounds.

For more information see Scientists Discover a Hidden Cause of Cellular Aging That Can Be Reversed and Aging-associated decline of phosphatidylcholine synthesis is a malleable trigger of natural mitochondrial aging - PubMed